18 months to accelerate your company and penetrate the European health market

Do you foresee clinical development and scientific collaboration in France and Europe? Is European commercialization a key factor for your company’s growth and development?

Located at the center of a busy crossroads for European business activity, Eurasante Accelerator aims to jump start medical startups and young companies looking to develop in Europe. Whether you innovate in software, hardware, a service, or a combination of these, our program will equip you to what you need to more effectively tackle the significant challenges specific to the MedTech/Digital Health industry. Our team of experts and partners will guide you through key topics such as value propositions, business modeling, reimbursement, IP, regulatory requirements, and many more.

The first project selected will have its entry into the acceleration program sponsored and will benefit from a €30,000 voucher (to be spent within the French entity*) :

  • Voucher : €10,000
  • Acceleration offered : €15,000
  • Soft landing package : €5,000

>> Apply before September 30th, 2020 <<

Many thanks to CEA Leti for joining MedFIT 2020 as a Contributing Sponsor!

Leti, a technology research institute at CEA Tech, pioneers micro and nanotechnologies, tailoring differentiating applicative solutions that ensure competitiveness in a wide range of markets. The institute tackles critical challenges such as healthcare, energy, transport and ICTs. Its multidisciplinary teams deliver solid expertise for applications ranging from sensors to data processing and computing solutions, leveraging world-class pre-industrialization facilities. Leti builds long-term relationships with its industrial partners – global companies, SMEs and startups – and actively supports the launch of technology startups. Leti is a member of the Carnot Institutes network.

Join key MedFIT 2020 Sponsors such as ICOSA, CEA Leti, EIT Health, Innov’Health and World Trade Center Twente to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to innovation partnerships in the fields of medical technologies and diagnostics.
  • Highlight your interest in innovation
  • Present your ideas and technologies to key innovation players in MedTech
  • Enhance your visibility on an european scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

Many thanks to EIT-Health for joining MedFIT 2020 as a Contributing Sponsor !

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives by promoting innovation. We connect the right people and the right topics across European borders, so that innovation can happen at the intersection of research, education and business – for the benefit of citizens.

Join key MedFIT 2020 Sponsors such as ICOSA, Innov’Health, EIT Health and World Trade Center Twente to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to innovation partnerships in the fields of medical technologies and diagnostics.
  • Highlight your interest in innovation
  • Present your ideas and technologies to key innovation players in MedTech
  • Enhance your visibility on an european scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

Due to the outbreak of the Coronavirus COVID-19 spreading around the world, MedFIT organisers (Eurasanté, Clubster-NHL, Medicalps and BioValley France) made the hard decision to postpone MedFIT 2020 initially scheduled to take place in Grenoble on June 30th & July 1st, 2020. Therefore, MedFIT 4th edition will be rescheduled on September 15th and 16th, 2020.

The safety and wellbeing of our participants is our number one priority, and given the uncertainties of the Coronavirus spread in the coming months, we believe it is wiser to reschedule the gathering at a later date. Additionally, the current confinement policies, the travel bans and the economic uncertainty faced by numerous countries make it difficult for MedFIT organisers to anticipate upcoming decisions and to deliver this 4th edition when planned initially.

The opportunity to meet and interact with international key innovators in the MedTech, diagnostic and digital health sectors is the core value of MedFIT and the MedFIT team will do its utmost to deliver a commensurate 2020 edition.

Your participation in MedFIT 2020:

We would like to reassure all participants who already booked their passes/exhibition stands on the fact that their purchases will remain unchanged and valid for the new dates on September 15th & 16th, 2020 in Grenoble.

If you are not available on these new dates, or for any questions regarding the current situation, please contact us so we can help you and find a solution.

In the meantime, we thank you for supporting MedFIT and we apologise for any inconvenience caused by this decision. Do not hesitate to let us know if you wish to get involved in this 4th edition and we look forward to meeting you in Grenoble on September 15th & 16th.

Many thanks to Innov’Health for joining MedFIT 2020 as a Contributing Sponsor!

The Microtechnology Competitiveness Cluster, approved in 2005, decided, with its industrial members and the public authorities (State, Region, EPCI, etc.), to highlight its market-oriented activities in the health sector. A brand and a “lnnov’Health” cluster were drawn up in 2015, reflecting the last 10 years of the Microtechniques Pole’s health activity, particularly through its expert groups led by business leaders from the medical and healthcare sectors. its “health commission” currently led by Statice and a consortium of companies.

The Bourgogne-Franche-Comté region, represents an industrial ecosystem that relies on historical skills in the field of microtechnology, much of which is dedicated to health. For over 10 years, more than 300 companies in the region have been referenced in the sector, most of them internationally recognized and relying on renowned training and research centers (French Blood Establishment (EFS), ISIFC, Femto , LERMPS, Utinam, Clinical Investigation Center (CIC) …).

Join key MedFIT 2020 Sponsors such as ICOSA, Innov’Health and World Trade Center Twente to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to innovation partnerships in the fields of medical technologies and diagnostics.
  • Highlight your interest in innovation
  • Present your ideas and technologies to key innovation players in MedTech
  • Enhance your visibility on an european scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

Many thanks to World Trade Center Twente for joining MedFIT 2020 as a Contributing Sponsor!

The World Trade Center Twente supports the development of international trade and business opportunities in the Twente region. The WTC Twente Business Club provides a business support environment to share experience and knowledge from every sector. We offer a range of supports for your business such as trade information, training, coaching, trade mission and our Expat Center assists the individuals as well as companies with highly skilled migrants and scientific researchers during the entire relocation process.

Join key MedFIT 2020 Sponsors such as ICOSA, Innov’Health and World Trade Center Twente to have the opportunity to:

  • Identify your organisation with the main partnering event in Europe dedicated to innovation partnerships in the fields of medical technologies and diagnostics.
  • Highlight your interest in innovation
  • Present your ideas and technologies to key innovation players in MedTech
  • Enhance your visibility on an european scale and be recognised as a key innovative actor
  • Show your expertise thanks to specific communication tools

Many thanks to ICOSA for joining MedFIT 2020 as a Silver Sponsor!

ICOSA is an IP law firm. Besides the regular services of an IP law firm, the specificity of ICOSA is to design IP strategy to serve business purposes.

Promoting IP activities in line with the Corporate Strategy, capturing IP value, leveraging company valuation through IP, is what we do on a daily basis.

Our expertise in IP and our high scientific level are tools to promote value, partnership, development and success.

Join a key MedFIT 2020 sponsor to have the opportunity to get unequalled and targeted visibility and exclusive benefits before, during and after the MedFIT event.

For more information about the sponsorship opportunities, visit the dedicated site page.

Connect with 750+ key innovators in the MedTech, diagnostic and digital health sectors by attending MedFIT on June 30th and July 1st, 2020 in Grenoble, France

Register before December 21st and benefit from an exclusive 15% discount on the regular full pass fees using the code:

 MedFIT_MerryChristmas

Register before December 21st and benefit from an exclusive 10% discount on the regular exhibition fees using the code:

 MedFITChristmas

Please note that these offers cannot be combined with the “Early Bird” offer

Discover the MedFIT 2020 brand new brochure!!

In this document, you’ll find all the information about the 4th edition of MedFIT, the European partnering event for innovation partnerships and investment rounds in the MedTech, Diagnostic and Digital Health sectors.

SepTec, elected as the most innovative Start-up in Europe

Among 80 applications, 30 start-ups were selected to pitch during the Start-up Slams at MedFIT in different categories such as cardiovascular, AI/Big data, cancer, generic tools, diagnostic, monitoring and coating / implants / wound. SepTec, an Irish start-up represented by Dr. Elaine Spain, co-founder and co-inventor, is the winner of this year’s edition of the Start-up Slams, from the diagnostic category.

SepTec was honored to be accepted to pitch at MedFIT 2019 in the Start-up Slams as well as being awarded a stand to showcase our technology. This not only gave us the opportunity to highlight the benefits of SepTec but to interact with international key opinion leaders and experts in MedTech and diagnostics. Winning the “most innovative start-up” award has already significantly enhanced SepTec’s visibility in all of these sectors. Dr. Elaine Spain – Co-founder and co-inventor

SepTec is developing a sample-to-answer IVD test that can rapidly detect sepsis causing pathogens in whole blood within 15 minutes. SepTec is composed of highly accomplished, aspiring entrepreneurial scientists, engineers and clinical key opinion leaders with a clear focus to address unmet clinical needs, such as empowering an ICU Consultant to rapidly detect infection in a seriously ill patient. In collaboration with Science foundation Ireland, Enterprise Ireland, Dublin City University, Business Experts and International Manufacturers, SepTec has created a powerful microfluidic device that can address the specific unmet clinical needs as expressed by their network of clinicians. SepTec is currently completing clinical device validation using suspected sepsis patient samples in collaboration with two Dublin based hospital locations and is determinedly  working to accelerate the SepTec device to the next stage of commercialisation.

Mikro Biyosistemler, elected as the most promising technology in Europe

35 TTOs, universities, research institutes and companies applied to the Collaborative and Licensing Opportunity Presentations to showcase their technology in front of potential partners in order to entail a collaborative project and / or a licensing deal. 11 of them have been selected to pitch during MedFIT in 4 different categories: cardiovascular/nutrition, imaging, injection/needle and diagnostic. Mikro Biyosistemler, founded in 2015 and represented by Özge Zorlu, CTO, received the “Most promising Technology” award.

We applied for a presentation at the Collaborative and Licensing Opportunities Presentations to introduce our new technology to our potential collaborators and investors. I was honored that we were granted with this prize among many brilliant ideas and presentations. We are very happy that we will be at MedFIT2020 as a result of this award. This will be the 3rd time in a row, and we already feel as a part of MedFIT. Özge Zorlu, PhD – CTO

Mikro Biyosistemler is a university spin-off developing biomedical microsystems. Their core product is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells from the blood samples of cancer patients. Mikro Biyosistemler plans to launch their first products in late 2020. Mikro Biyosistemler recently started working on a new product which is a rapid point-of-care diagnostic finger prick blood test which gives White Blood Cell differential count to assess whether the infection is bacterial or viral, aimed to reduce unnecessary prescription of antibiotics. Mikro Biyosistemler is in collaboration with several Turkish and other European hospitals and companies for the validation of their products.